Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine for activation of the cholinergic anti-inflammatory pathway in CRPS-1
2009-010758-36Phase 2Completed
- Sponsor
- VU University Medical Center
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of pyridostigmine in Complex Regional Pain Syndrome Type 1 (CRPS-1), sponsored by VU University Medical Center. Primary endpoint: Improvement of functional status. Started Mar 2009; status: completed.
02
Drugs
pyridostigmine
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on 2009-010758-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010758-36.